Amy Olson is a Respiratory physician affiliated with Boehringer Ingelheim. OpenAlex indexes 108 publications with 6,191 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 17 Mar 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20221 payment
- Boehringer Ingelheim International GmbHProgram year20211 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.6%Corticosteroid22.3%Prednisone100%Part D<11 patientsH2 blocker11.2%Famotidine100%Part D<11 patients+ 1 more class in this area
Respiratory
23.9%beta2-Adrenergic Agonist12.2%Ventolin Hfa54%Albuterol Sulfate Hfa46%Part D<11 patientsCorticosteroid11.7%Symbicort52%Fluticasone Propionate48%Part D<11 patientsCancer & immunology
19.8%Kinase inhibitor13.7%Ofev100%Part D<11 patientsPyridone6.1%Esbriet100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Hans Juergen Woerle
Boehringer Ingelheim
Martina Brueckmann
Boehringer Ingelheim
Paul A. Reilly
Boehringer Ingelheim
Stefan Hantel
Boehringer Ingelheim
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”